E-LIB Suche - Ergebnisse für: Häring, Dieter

1

New strategies for confirmatory testing of secondary hypoth..:

Vandemeulebroecke, Marc ; Häring, Dieter A ; Hua, Eva..
Clinical Trials. , 2024

Link: https://doi.org/10.1177/..

2

The Development of Ofatumumab, a Fully Human Anti-CD20 Mono..:

Hauser, Stephen L. ; Kappos, Ludwig ; Bar-Or, Amit...
Neurology and Therapy. 12 (2023) 5 - p. 1491-1515 , 2023

Link: https://doi.org/10.1007/..

3

Statistical Considerations in Pediatric Cancer Trials: Repo..:

Sridhara, Rajeshwari ; Marchenko, Olga ; Jiang, Qi...
Statistics in Biopharmaceutical Research. 15 (2023) 4 - p. 845-851 , 2023

Link: https://doi.org/10.1080/..

4

Application of a convolutional neural network to the qualit..:

Delbarre, Daniel J. ; Santos, Luis ; Ganjgahi, Habib...
Computers in Biology and Medicine. 151 (2022) - p. 106211 , 2022

Link: https://doi.org/10.1016/..

5

Reader Response: Serum Neurofilament Light Association With..:

Kropshofer, Harald ; Häring, Dieter A. ; Kappos, Ludwig..
Neurology. 98 (2022) 11 - p. 470-471 , 2022

Link: https://doi.org/10.1212/..

6

How patients with multiple sclerosis acquire disability:

Lublin, Fred D ; Häring, Dieter A ; Ganjgahi, Habib...
Brain. 145 (2022) 9 - p. 3147-3161 , 2022

Link: https://doi.org/10.1093/..

7

Author Response: Blood Neurofilament Light in Progressive M..:

Leppert, David ; Kropshofer, Harald ; Häring, Dieter...
Neurology. 99 (2022) 14 - p. 631-631 , 2022

Link: https://doi.org/10.1212/..

8

Population Pharmacokinetic–B Cell Modeling for Ofatumumab i..:

Yu, Huixin ; Graham, Gordon ; David, Olivier J....
CNS Drugs. 36 (2022) 3 - p. 283-300 , 2022

Link: https://doi.org/10.1007/..

9

Improving pediatric multiple sclerosis interventional phase..:

Graves, Jennifer S. ; Thomas, Marius ; Li, Jun...
Therapeutic Advances in Neurological Disorders. 15 (2022) - p. 175628642110704 , 2022

Link: https://doi.org/10.1177/..

10

Prognostic Value of Serum Neurofilament Light Chain for Dis..:

Ziemssen, Tjalf ; Arnold, Douglas L. ; Alvarez, Enrique...
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

11

Safety experience with continued exposure to ofatumumab in ..:

Hauser, Stephen L ; Cross, Anne H ; Winthrop, Kevin...
Multiple Sclerosis Journal. 28 (2022) 10 - p. 1576-1590 , 2022

Link: https://doi.org/10.1177/..

12

Blood Neurofilament Light in Progressive Multiple Sclerosis..:

Leppert, David ; Kropshofer, Harald ; Häring, Dieter A....
Neurology. 98 (2022) 21 - p. , 2022

Link: https://doi.org/10.1212/..

13

Systematic review and network meta‐analysis comparing ofatu..:

Drudge, Christopher ; Zhao, Melody ; Tanaka, Satoru...
Clinical and Experimental Neuroimmunology. 13 (2022) 4 - p. 234-245 , 2022

Link: https://doi.org/10.1111/..

14

Simulated treatment comparison of efficacy outcomes for ofa..:

Samjoo, Imtiaz A. ; Klotz, Luisa ; Giovannoni, Gavin...
Multiple Sclerosis and Related Disorders. 66 (2022) - p. 104031 , 2022

Link: https://doi.org/10.1016/..

15

Serum Neurofilament Light Trajectories and Their Relation t..:

Bar-Or, Amit ; Montalban, Xavier ; Hu, Xixi...
Neurology and Therapy. 12 (2022) 1 - p. 303-317 , 2022

Link: https://doi.org/10.1007/..